Eva Sutinen

1.0k total citations
33 papers, 630 citations indexed

About

Eva Sutinen is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Eva Sutinen has authored 33 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Eva Sutinen's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (25 papers), Occupational and environmental lung diseases (15 papers) and Pleural and Pulmonary Diseases (7 papers). Eva Sutinen is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (25 papers), Occupational and environmental lung diseases (15 papers) and Pleural and Pulmonary Diseases (7 papers). Eva Sutinen collaborates with scholars based in Finland, Sweden and United States. Eva Sutinen's co-authors include Marjukka Myllärniemi, Juho T. Lehto, Tiina Saarto, Hannu Kautiainen, Maiju Saarinen, Katri Koli, Riitta Kaarteenaho, Mikko Rönty, Anne Pietinalho and Leena Huhti and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Eva Sutinen

31 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Sutinen Finland 15 506 178 71 69 44 33 630
Carlos Aravena Chile 12 689 1.4× 293 1.6× 37 0.5× 109 1.6× 40 0.9× 28 796
Mark Edwin United States 4 777 1.5× 244 1.4× 32 0.5× 74 1.1× 104 2.4× 7 853
Sarah L. O’Beirne United States 12 249 0.5× 65 0.4× 103 1.5× 26 0.4× 61 1.4× 28 523
R A Helmers United States 8 866 1.7× 295 1.7× 28 0.4× 64 0.9× 106 2.4× 8 921
Ariffin Nasir Malaysia 11 91 0.2× 69 0.4× 77 1.1× 47 0.7× 33 0.8× 37 369
A. Prudhomme France 12 336 0.7× 318 1.8× 28 0.4× 12 0.2× 18 0.4× 31 508
Drew Cutler United States 11 87 0.2× 149 0.8× 53 0.7× 31 0.4× 41 0.9× 21 377
Ann Roosaar Sweden 11 175 0.3× 75 0.4× 66 0.9× 36 0.5× 59 1.3× 14 525
William J. Grist United States 12 189 0.4× 50 0.3× 50 0.7× 19 0.3× 55 1.3× 15 487

Countries citing papers authored by Eva Sutinen

Since Specialization
Citations

This map shows the geographic impact of Eva Sutinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Sutinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Sutinen more than expected).

Fields of papers citing papers by Eva Sutinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Sutinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Sutinen. The network helps show where Eva Sutinen may publish in the future.

Co-authorship network of co-authors of Eva Sutinen

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Sutinen. A scholar is included among the top collaborators of Eva Sutinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Sutinen. Eva Sutinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lahtinen, Laura, Mikko Räsänen, Karita Peltonen, et al.. (2024). Ex vivo modeling of precision immuno-oncology responses in lung cancer. Science Advances. 10(44). eadq6830–eadq6830. 2 indexed citations
2.
3.
Hollmén, Maria, Juulia Partanen, Jukka Koskela, et al.. (2023). KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis. Respiratory Research. 24(1). 240–240. 4 indexed citations
4.
Mäyränpää, Mikko I., Lassi Paavolainen, Juuso Paajanen, et al.. (2022). Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma. Frontiers in Oncology. 12. 870352–870352. 5 indexed citations
5.
Kettunen, Eeva, Eva Sutinen, Ilkka Ilonen, et al.. (2022). Pulmonary Asbestos Fiber Burden Is Related to Patient Survival in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 17(8). 1032–1041. 6 indexed citations
6.
Repo, Pauliina, Eva Sutinen, Mikko Rönty, et al.. (2022). BAP1 germline variants in Finnish patients with malignant mesothelioma. Lung Cancer. 165. 102–107. 7 indexed citations
7.
Paajanen, Juuso, Eeva Kettunen, Ilkka Ilonen, et al.. (2020). Histopathological features of epithelioid malignant pleural mesotheliomas in patients with extended survival. Human Pathology. 98. 110–119. 12 indexed citations
8.
Mäyränpää, Mikko I., et al.. (2020). Artificial intelligence identifies inflammation and confirms fibroblast foci as prognostic tissue biomarkers in idiopathic pulmonary fibrosis. Human Pathology. 107. 58–68. 38 indexed citations
9.
Lehto, Juho T., Eva Sutinen, Hannu Kautiainen, et al.. (2020). Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis. SHILAP Revista de lepidopterología. 6(4). 347–2020. 7 indexed citations
10.
Paajanen, Juuso, Ilkka Ilonen, Tapio Vehmas, et al.. (2020). Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses. Clinical Lung Cancer. 21(6). e633–e639. 6 indexed citations
11.
Saraswat, Mayank, Sakari Joenväärä, Eva Sutinen, et al.. (2020). Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways. Scientific Reports. 10(1). 7787–7787. 13 indexed citations
12.
Paajanen, Juuso, Ilkka Ilonen, Eva Sutinen, et al.. (2019). Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy. Clinical Lung Cancer. 21(3). e142–e150. 24 indexed citations
13.
Sutinen, Eva, et al.. (2019). Inorganic particulate matter in the lung tissue of idiopathic pulmonary fibrosis patients reflects population density and fine particle levels. Annals of Diagnostic Pathology. 40. 136–142. 15 indexed citations
14.
Lehto, Juho T., et al.. (2018). Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life. BMC Pulmonary Medicine. 18(1). 172–172. 49 indexed citations
15.
Lehto, Juho T., et al.. (2017). mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis. ERJ Open Research. 3(4). 84–2017. 78 indexed citations
16.
Lehto, Juho T., et al.. (2016). End-of-life care of patients with idiopathic pulmonary fibrosis. BMC Palliative Care. 15(1). 85–85. 72 indexed citations
17.
Yin, Miao, Mikko Rönty, Eva Sutinen, et al.. (2015). Overexpression of activin-A and -B in malignant mesothelioma – Attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth. Experimental Cell Research. 332(1). 102–115. 25 indexed citations
18.
Sutinen, Eva, Ulla Hodgson, Anneli Piilonen, et al.. (2015). Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis. BMC Pulmonary Medicine. 15(1). 92–92. 38 indexed citations
19.
Syrjä, Pernilla, Eva Sutinen, Mikko Rönty, et al.. (2013). Comparative Study of Transforming Growth Factor-β Signalling and Regulatory Molecules in Human and Canine Idiopathic Pulmonary Fibrosis. Journal of Comparative Pathology. 150(4). 399–407. 18 indexed citations
20.
Pulkkinen, Ville, Kaisa Salmenkivi, Vuokko L. Kinnula, et al.. (2011). A novel screening method detects herpesviral DNA in the idiopathic pulmonary fibrosis lung. Annals of Medicine. 44(2). 178–186. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos Aravena Breakdown of academic impact, for papers by Mark Edwin Breakdown of academic impact, for papers by Sarah L. O’Beirne Breakdown of academic impact, for papers by R A Helmers Breakdown of academic impact, for papers by Ariffin Nasir Breakdown of academic impact, for papers by A. Prudhomme Breakdown of academic impact, for papers by Drew Cutler Breakdown of academic impact, for papers by Ann Roosaar Breakdown of academic impact, for papers by William J. Grist
Rankless by CCL
2026